Loading company details...
Latest Form 4 (Dec 30, 2025): GENMAB A/S (10% Owner): Purchase of 2,978 shares, $288.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 30, 2025 | GENMAB A/S | Purchase | 2,978 | $288.9K |
| Dec 29, 2025 | GENMAB A/S | Purchase | 15,710 | $1.52M |
| Dec 22, 2025 | GENMAB A/S | Purchase | 212,177 | $20.58M |
| Dec 18, 2025 | GENMAB A/S | Purchase | 120,752 | $11.71M |
| Dec 13, 2025 | Gregory D. Perry, Chief Financial Officer & PFO | Disposition to Issuer | 100,000 | n/a |
| Dec 13, 2025 | Anand Mehra | Disposition to Issuer | 13,193 | n/a |
| Dec 13, 2025 | Len Kanavy | Disposition to Issuer | 13,193 | n/a |
| Dec 13, 2025 | Jason Haddock | Disposition to Issuer | 13,193 | n/a |
| Dec 13, 2025 | Peter B. Silverman, COO & GC | Disposition to Issuer | 50,000 | n/a |
| Dec 13, 2025 | Fabian Zohren, Chief Medical Officer | Disposition to Issuer | 50,000 | n/a |